SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011822
Filing Date
2021-05-17
Accepted
2021-05-17 16:00:53
Documents
57
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 550997
2 ex10-1.htm EX-10.1 110148
3 ex10-2.htm EX-10.2 115130
4 ex31-1.htm EX-31.1 20039
5 ex31-2.htm EX-31.2 20442
6 ex32.htm EX-32 14037
7 image_013.jpg GRAPHIC 53250
8 image_012.jpg GRAPHIC 5601
9 image_001.jpg GRAPHIC 6317
  Complete submission text file 0001493152-21-011822.txt   3641685

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE abeo-20210331.xsd EX-101.SCH 25149
11 XBRL CALCULATION FILE abeo-20210331_cal.xml EX-101.CAL 46527
12 XBRL DEFINITION FILE abeo-20210331_def.xml EX-101.DEF 86672
13 XBRL LABEL FILE abeo-20210331_lab.xml EX-101.LAB 229664
14 XBRL PRESENTATION FILE abeo-20210331_pre.xml EX-101.PRE 182899
15 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 433640
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Filer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 21930152
SIC: 2834 Pharmaceutical Preparations